Page last updated: 2024-10-31

mosapramine and Chronic Illness

mosapramine has been researched along with Chronic Illness in 1 studies

mosapramine: structure given in first source
mosapramine : A racemate comprising equimolar amounts of (R)- and (S)-mosapramine. It is a second-generation antipsychotic used for the treatment of schizophrenia.
1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(2-oxohexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-1'-yl)propyl group.

Research Excerpts

ExcerptRelevanceReference
"There is little information regarding the effects of risperidone addition to neuroleptic treatment in chronic schizophrenia."9.09Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. ( Oga, T; Okada, M; Takahashi, N; Terao, T, 1999)
"There is little information regarding the effects of risperidone addition to neuroleptic treatment in chronic schizophrenia."5.09Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. ( Oga, T; Okada, M; Takahashi, N; Terao, T, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, N1
Terao, T1
Oga, T1
Okada, M1

Trials

1 trial available for mosapramine and Chronic Illness

ArticleYear
Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia.
    Neuropsychobiology, 1999, Volume: 39, Issue:2

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Behavioral Symptoms; Benzazepines; Chronic Diseas

1999